Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease

Herbert Decaluwé, Christophe Dooms, Paul De Leyn, Pascal Thomas, Ramon Rami-Porta

Source: Eur Respir J, 51 (4) 1800410; 10.1183/13993003.00410-2018
Journal Issue: April
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Herbert Decaluwé, Christophe Dooms, Paul De Leyn, Pascal Thomas, Ramon Rami-Porta. Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease. Eur Respir J, 51 (4) 1800410; 10.1183/13993003.00410-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of lung adenocarcinoma in patients aged 70 and over: The viewpoint of clinical stage, therapeutic modality and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 269s
Year: 2002

Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003


Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


Timing of radiotherapy and possible survival benefit in limited disease SCLC patients
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017

Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018



Does large airway intervention for patients with malignant disease result in early clinical benefit
Source: Eur Respir J 2007; 30: Suppl. 51, 434s
Year: 2007

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Guideline 2009
Year: 2009


Locally advanced disease – indications and results of extended resections
Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer
Year: 2005

Would lung cancer patients benefit from prehabilitation before surgery? Selecting optimisable patient variables.
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019




Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Does large airway intervention for patients with malignant disease result in early clinical benefit?
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008


Clinical characteristics, treatment, and prognosis of lung cancer elderly patients
Source: Eur Respir J 2001; 18: Suppl. 33, 228s
Year: 2001

The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011

The effect of nutritional indicators on prognosis of patients with advanced lung cancer
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019

Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 752s
Year: 2006

Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer?
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012